Loading clinical trials...
Loading clinical trials...
A Phase I Dose Escalation Study With Sunitinib (SutentR) in Combination With Capecitabine and Irinotecan (Capiri) in Previously Treated Patients With Advanced Colorectal Cancer
Conditions
Interventions
capiri-sutent
Locations
1
Netherlands
University Medical Center Nijmegen st Radboud
Nijmegen, Gelderland, Netherlands
Start Date
December 1, 2008
Primary Completion Date
May 1, 2012
Completion Date
December 1, 2012
Last Updated
February 3, 2012
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
Radboud University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions